Cullen/Frost Bankers, Inc. Novo Cure LTD Transaction History

Cullen/Frost Bankers, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 07, 2022	BUY	$67.99 - $89.57 $611 - $806	9 New	9 $1,000
Q4 2021 Feb 07, 2022	SELL	$75.08 - $121.99 $22,524 - $36,597	-300 Closed	0 $0
Q3 2021 Nov 04, 2021	BUY	$116.17 - $194.55 $34,851 - $58,365	300 New	300 $35,000
Q4 2020 Feb 08, 2021	SELL	$112.16 - $174.14 $336 - $522	-3 Closed	0 $0
Q3 2020 Nov 05, 2020	BUY	$58.05 - $111.31 $174 - $333	3 New	3 $0

263

77M

1.17M

318K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $3.37B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Cullen/Frost Bankers, Inc., based on Form 13F filings with the SEC.

Stay updated on Cullen/Frost Bankers, Inc. with notifications on news.